PREDIERI, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 19.792
EU - Europa 19.226
AS - Asia 3.795
SA - Sud America 211
OC - Oceania 117
AF - Africa 107
Continente sconosciuto - Info sul continente non disponibili 14
Totale 43.262
Nazione #
US - Stati Uniti d'America 19.537
IT - Italia 9.908
GB - Regno Unito 3.920
SE - Svezia 1.497
CN - Cina 1.312
DE - Germania 1.016
UA - Ucraina 737
HK - Hong Kong 715
FR - Francia 566
SG - Singapore 546
TR - Turchia 492
FI - Finlandia 409
BG - Bulgaria 295
IN - India 186
IE - Irlanda 138
CA - Canada 136
CH - Svizzera 122
ID - Indonesia 116
AU - Australia 102
BR - Brasile 87
IR - Iran 82
BZ - Belize 73
ES - Italia 73
JP - Giappone 73
RU - Federazione Russa 72
BE - Belgio 69
VN - Vietnam 63
LT - Lituania 60
DK - Danimarca 55
NL - Olanda 51
MY - Malesia 50
CZ - Repubblica Ceca 47
EC - Ecuador 43
EG - Egitto 38
MX - Messico 37
PL - Polonia 34
RO - Romania 32
KR - Corea 27
PK - Pakistan 25
TH - Thailandia 25
VE - Venezuela 24
AR - Argentina 21
GR - Grecia 21
TW - Taiwan 18
PT - Portogallo 17
ZA - Sudafrica 17
PE - Perù 16
NZ - Nuova Zelanda 15
IQ - Iraq 14
EU - Europa 13
RS - Serbia 13
SM - San Marino 13
PH - Filippine 10
ET - Etiopia 9
SA - Arabia Saudita 9
KW - Kuwait 8
NO - Norvegia 8
AT - Austria 7
CL - Cile 7
HU - Ungheria 7
MA - Marocco 7
MT - Malta 7
NG - Nigeria 7
CO - Colombia 6
DZ - Algeria 6
EE - Estonia 6
IL - Israele 5
LK - Sri Lanka 5
SI - Slovenia 5
GH - Ghana 4
HR - Croazia 4
KE - Kenya 4
UG - Uganda 4
UY - Uruguay 4
CR - Costa Rica 3
ME - Montenegro 3
MK - Macedonia 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BO - Bolivia 2
BT - Bhutan 2
DO - Repubblica Dominicana 2
KZ - Kazakistan 2
MD - Moldavia 2
NA - Namibia 2
OM - Oman 2
TD - Ciad 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CM - Camerun 1
HN - Honduras 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LI - Liechtenstein 1
LU - Lussemburgo 1
Totale 43.251
Città #
Southend 3.321
Fairfield 2.253
Chandler 1.624
Woodbridge 1.600
Houston 1.517
Ashburn 1.391
Jacksonville 1.354
Dearborn 1.130
Nyköping 888
Ann Arbor 856
Seattle 816
Wilmington 801
Cambridge 686
Milan 677
Hong Kong 667
Rome 618
Beijing 413
Singapore 342
Princeton 325
Sofia 282
Naples 258
Eugene 253
San Diego 247
Modena 242
Bologna 235
New York 235
Redwood City 217
Helsinki 206
Izmir 206
Palermo 202
Bremen 183
Turin 180
San Jose 177
Bari 116
Catania 112
Shanghai 112
London 105
Padova 103
Dublin 100
Jakarta 98
Fremont 97
Des Moines 93
Florence 92
Parma 91
Verona 84
Boardman 80
Albuquerque 76
Belize City 73
Falls Church 70
Las Vegas 70
Dong Ket 61
Genoa 58
Dallas 53
Norwalk 52
Nanjing 51
Brescia 48
Pescara 47
Toronto 47
Hefei 44
Cagliari 43
Reggio Nell'emilia 41
Torino 39
Brussels 38
Odense 38
Brno 37
Guangzhou 36
Kunming 36
Saint Louis 36
Paris 35
Menlo Park 34
Napoli 34
Caserta 31
Munich 31
Philadelphia 31
Pavia 30
Treviso 30
Chicago 29
Columbus 29
Mumbai 29
Reggio Emilia 29
Bergamo 28
Phoenix 28
Salerno 28
Frankfurt am Main 27
Grafing 27
Ottawa 27
Novellara 26
Leawood 25
Perugia 25
Augusta 24
Dongguan 24
Tehran 24
Messina 23
Portici 23
San Mateo 23
Wuhan 23
Monza 22
Mountain View 22
Trieste 22
Istanbul 21
Totale 27.643
Nome #
CASO CLINICO: SINDROME DA MICRODELEZIONE 16p11.2 PROSSIMALE 3.876
Diabete tipo 2 e obesità pediatrica: rassegna a cura dei Gruppi di Studio Obesità Infantile e Diabete della Società Italiana di Endocrinologia e Diabetologia Pediatrica 907
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 737
I DISORDINI DELLO SVILUPPO SESSUALE E LE MALFORMAZIONI DELL’APPARATO GENITALE 717
Gestione del Covid-19 in età pediatrica: documento di consenso 617
Switching From Glargine to Degludec: The Effect on Metabolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes 567
Effetti degli interferenti endocrini su crescita e sviluppo puberale 484
Si può “Valere” di più: un progetto italiano studia i disturbi alimentari negli adolescenti con diabete tipo 1. Dati preliminari 482
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 377
Lactobacillus reuteri oral administration improves periodontal disease in children and adolescents with type 1 diabetes 315
Hypospadias: clinical approach, surgical technique and outcome. Twenty years’ experience of a single centre 304
BODY EMOTIONAL MAP: STRUMENTO INNOVATIVO ED UTILE PER MIGLIORARE L’ADATTAMENTO DEI GENITORI ALLA DIAGNOSI DI DIABETE DI TIPO 1 DEL LORO BAMBINO 298
COMPLICANZE MACROVASCOLARI E MORTALITÀ NEL DIABETE TIPO 1 286
Oral Administration of Lactobacillus Reuteri Improves Periodontal Disease in Children and Adolescents with Type 1 Diabetes 277
Effects of Exercise in Children and Adolescent with Type 1 Diabetes Mellitus 259
Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: An Italian cohort study 254
Long-term effects on growth, development, and metabolism of ALL treatment in childhood 252
Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian Meeting 251
Childhood obesity and environmental pollutants: a dual relationship 242
DETERMINANTI DELLA HEALTH RELATED QUALITY OF LIFE (HRQOL) IN ADOLESCENTI OBESI ITALIANI 240
Effect of Weight Loss on Markers of Inflammation and Endothelial Function in Childhood Obesity 236
THE IMPACT OF SENSOR-AUGMENTED INSULIN PUMP (SAP) THERAPY ON QUALITY OF LIFE (QOL) IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES (T1D) AND THEIR PARENTS 235
MALATTIA PARODONTALE IN BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1: EFFICACIA DELLA SOMMINISTRAZIONE ORALE DI LACTOBACILLUS REUTERI 235
Diabetic ketoacidosis at the onset of disease during a national awareness campaign: a 2-year observational study in children aged 0-18 years 225
CONSEGUENZE METABOLICHE A BREVE E LUNGO TERMINE IN PAZIENTI CON PUBERTÀ PRECOCE CENTRALE TRATTATI CON GNRHA IN ETÀ EVOLUTIVA: STUDIO LONGITUDINALE MONOCENTRICO 222
Accuracy of SenseWear Pro2 armband to predict resting energy expenditure in childhood obesity. 222
Central Precocious Puberty and Response to GnRHa Therapy in Children with Cerebral Palsy and Moderate to Severe Motor Impairment: Data from a Longitudinal, Case-Control, Multicentre, Italian Study 219
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 216
Longitudinal evaluation of endothelial function in children and adolescents with type 1 diabetes mellitus: a long term follow up study. 207
IPERTENSIONE IN BAMBINI ED ADOLESCENTI AFFETTI DA DIABETE DI TIPO 1: ALTA PREVALENZA IDENTIFICATA TRAMITE L’UTILIZZO DEL MONITORAGGIO PRESSORIO AMBULATORIALE 200
L’ipercolesterolemia familiare: terapia farmacologica 199
Safety outcomes during pediatric GH therapy: final results from the prospective GeNeSIS observational program 198
Dolore addominale acuto nelle adolescenti: le principali patologie di natura ginecologica 198
Weekend-Based Parent-Group Intervention to Reduce Stress in Parents of Children and Adolescents with Type 1 Diabetes: A Pilot Study 193
Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: The RIDI study 191
Abdominal adiposity and cardiovascular risk factors in adolescents with type 1 diabetes. 191
Unusual presentation of Rosai-Dorfman disease in a 14-month-old Italian child: a case report and review of the literature 187
Alti livelli di anticorpi antitransglutaminasi predicono la malattia celiaca in bambini e adolescenti italiani con diabete mellito tipo 1. 185
Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry 184
Confocal microscopy: Improving our understanding of nevogenesis 183
Anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to linear-growth impairment. 181
Rhabdomyoma of a rare type in a child: Case report and literature review 180
Efficacy and safety of insulin degludec in children and adolescents with type 1 diabetes 180
IMPATTO DELLA TERAPIA CON ANALOGO DEL GNRH SULLA QUALITÀ DELLA VITA DEI PAZIENTI CON CPP E DELLE LORO FAMIGLIE 178
Complex disease phenotype revealed by GH deficiency associated with a novel and unusual defect in the GH-1 gene. 178
Novel insights on the treatment of hypercholesterolemia 175
Pituitary height and neuroradiological alterations in patients with Prader-Labhart-Willi syndrome. 175
Thirty-year persistence of obesity after presentation to a pediatric obesity clinic. 174
Endocrine and Metabolic Complications in Children and Adolescents with Sickle Cell Disease: An Italian Cohort Study 173
Hypercholesterolemia in Childhood 173
Plasma brain-derived neurotrophic factor concentrations in children and adolescents. 172
Brain-derived neurotrophic factor and epilepsy: a systematic review 172
High basal serum allopregnanolone levels in overweight girls 171
A Multicenter Retrospective Survey regarding Diabetic Ketoacidosis Management in Italian Children with Type 1 Diabetes 171
Thyroid function in patients with Prader-Willi syndrome: an Italian multicenter study of 339 patients 171
Relationship between body mass index and insulin measured during oral glucose tolerance testing in severely obese children and adolescents 170
Glycemic Control in Kenyan Children and Adolescents with Type 1 Diabetes Mellitus 168
Isolated hypoaldosteronism as first sign of X-linked adrenal hypoplasia congenita caused by a novel mutation in NR0B1/DAX-1 gene: a case report 164
Iper CPKemia, non solo miopatie 164
High serum allopregnanolone levels in girls with precocious puberty 163
Tracheobronchial anomalies in chromosome 22q11.2 microdeletion 162
Impaired GH Secretion in Patients with SHOX Deficiency and Efficacy of Recombinant Human GH Therapy. 161
EFFICACIA E SICUREZZA DI DEGLUDEC NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 160
Evaluation and management of hyperlipidemia in children and adolescents. 159
Organization and regional distribution of centers for the management of children and adolescents with diabetes in Italy 159
VALUTAZIONE AUXO-ENDOCRINOLOGICA DEI PAZIENTI AFFETTI DA SICKLE CELL DISEASE (SCD): DATI PRELIMINARI 159
Endocrine Disrupting Chemicals and Type 1 Diabetes 159
High Levels of Perfluorooctane Sulfonate in Children at the Onset of Diabetes 158
Obesity in pediatric age: The analysis of genomic rearrangements 158
Approaches to dyslipidemia treatment in children and adolescents. 157
Final height and body mass index in adult survivors of childhood acute lymphoblastic leukemia treated without cranial radiotherapy: a retrospective longitudinal multicenter Italian study. 157
Natural history of congenital hypothyroidism in the last two decades: what is changing? Experience of a single tertiary Italian paediatric centre 156
Pharmacological treatment of obesity in children and adolescents: present and future. 155
Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure. 155
Ten-Year Longitudinal Study of Thyroid Function in Children with Down's Syndrome 155
Thyroid function in Down syndrome 155
Insulin pump failures in Italian children with Type 1 diabetes: retrospective 1-year cohort study 155
High levels of serum perfluorinated compounds in children and adolescents with endocrine autoimmune disease 155
Low-density lipoprotein oxidizability in children with chronic renal failure 154
High levels of serum perfluorinated compounds in children with endocrine autoimmune disease. 153
High prevalence of hypertension in children and adolescents with type 1 diabetes identified through the 24 hours ambulatory blood pressure monitoring 152
Low serum allopregnanolone levels in girls with precocious pubarche 151
Recommendations for self-monitoring in pediatric diabetes: a consensus statement by the ISPED. 151
A 1-year long-term study on efficacy and safety of degludec in children and adolescents with type 1 diabetes 151
SHORT STATURE HOMEOBOX-CONTAINING GENE AND IDIOPATHIC SHORT STATURE 150
Continuous subcutaneous insulin infusion in Italy: third national survey 149
Younger age at diagnosis of type 1 diabetes mellitus in children of immigrated families born in Italy. 148
In children with autoimmune thyroid diseases the association with Down syndrome can modify the clustering of extra-thyroidal autoimmune disorders 147
Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: A review 145
QUALITÀ DI VITA E CONTROLLO METABOLICO NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 E NEI LORO GENITORI PRIMA E DOPO IL LOCKDOWN PER COVID-19. 145
Lipide profile, antioxidant factors and endothelial function in children and adolescent with type 1 diabetes mellitus 144
COVID-19 and Type 1 Diabetes: Concerns and Challenges 144
Elevata incidenza di Diabete tipo 1 tra i bambini di famiglie migranti provenienti dal Nord Africa nella regione Emilia Romagna. 144
Efficacy and Safety of Degludec in Children and Adolescents with Type 1 Diabetes 143
In Children with Autoimmune Thyroid Diseases the Association with Down syndrome can Modify the Clustering of Extra-Thyroidal Autoimmune Disorders 141
Growth hormone impaired secretion and antipituitary antibodies in patients with coeliac disease and poor catch-up growth after a long gluten-free diet period: a causal association? 140
Prader Willi syndrome and growth hormone treatment in children and adults. 138
Whole lipid profile and not only HDL cholesterol is impaired in children with coexisting type 1 diabetes and untreated celiac disease 137
Unexpected phenotype in a boy with trisomy of the SHOX gene. 137
Peculiarities of presentation and evolution over time of Hashimoto's thyroiditis in children and adolescents with Down's syndrome 137
Totale 25.357
Categoria #
all - tutte 151.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.890


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.247 0 0 189 368 731 1.124 1.246 848 640 351 487 263
2020/20217.088 611 223 516 833 729 541 952 630 405 694 549 405
2021/20226.054 208 655 466 561 343 392 309 405 625 466 933 691
2022/20237.655 723 631 466 588 825 923 366 760 927 382 600 464
2023/20247.290 389 447 495 698 983 694 585 870 416 427 571 715
2024/20251.393 572 469 352 0 0 0 0 0 0 0 0 0
Totale 44.055